Vivo Capital, Llc - Net Worth and Insider Trading

Vivo Capital, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Capital, Llc owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .

Click here to see the complete history of Vivo Capital, Llc’s form 4 insider trades.

Insider Ownership Summary of Vivo Capital, Llc

Ticker	Comapny	Transaction Date	Type of Owner
CRNX	Crinetics Pharmaceuticals Inc	2018-07-17	10 percent owner

Vivo Capital, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vivo Capital, Llc Ownership Network

Ownership Network List of Vivo Capital, Llc

No Data

Ownership Network Relation of Vivo Capital, Llc

Vivo Capital, Llc Owned Company Details

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Vivo Capital, Llc is the 10 percent owner of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Scientific Officer Stephen F. Betz , See Remarks Marc Wilson , and Chief Operating Officer Jeff E. Knight .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Vivo Capital, Llc made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 134,049 shares made by Marc Wilson , and a net sale of 85,509 shares made by Dana Pizzuti .

In summary, during the past 3 months, insiders sold 174,051 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 174,051 shares. During the past 18 months, 882,807 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 877,807 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

Vivo Capital, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Capital, Llc. You might contact Vivo Capital, Llc via mailing address: 192 Lytton Avenue, Palo Alto Ca 94301.

Discussions on Vivo Capital, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.